ArticleeNeuro

Use of a Self-Delivering Anti-CCL3 FANA Oligonucleotide as an Innovative Approach to Target Inflammation after Spinal Cord Injury.

Nicolas Pelisch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.